Search
+

Dr. Reddy's Laboratories Share Price

  • 5,587.00157.90 (2.90%)
  • Volume: 6,20,391
  • Closed
  • Last Updated On: 29 Sep, 2023, 03:55 PM IST
Loading...

Dr. Reddys share price insights

View All
  • Company delivered ROE of 19.35% in year ending 31 Mar, 2023 outperforming its 5 year avg. of 14.06%. (Source: Consolidated Financials)

  • Company's annual revenue growth of 16.78% outperformed its 3 year CAGR of 12.22%. (Source: Consolidated Financials)

  • Weekly MACD crossover appeared on week ending Sep 29, 2023. Average price decline of -4.98% within 7 weeks of this signal in last 10 years.

  • Dr. Reddys is a part of Growth at Reasonable Price Screener

  • Dr. Reddy's Laboratories Ltd. share price moved up by 2.90% from its previous close of Rs 5,429.10. Dr. Reddy's Laboratories Ltd. stock last traded price is 5,587.00

    Share PriceValue
    Today/Current/Last5,587.00
    Previous Day5,429.105,425.55

InsightsDr. Reddys

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    19.70
    EPS - TTM
    (₹)
    283.58
    MCap
    (₹ Cr.)
    93,054.56
    Sectoral MCap Rank
    4
    PB Ratio
    (x)
    4.16
    Div Yield
    (%)
    0.72
    Face Value
    (₹)
    5.00
    Beta

    Beta

    1 Month0.75
    3 Months0.70
    6 Months0.21
    1 Year0.40
    3 Years0.54

    0.75
    VWAP
    (₹)
    5,583.20
    52W H/L
    (₹)
    5,989.70 / 4,175.10

    Dr. Reddys Share Price Returns

    1 Day2.9%
    1 Week1.27%
    1 Month-2.39%
    3 Months9.38%
    1 Year28.12%
    3 Years9.89%
    5 Years120.77%

    ET Stock ScreenersTop Score Companies

    Check whether Dr. Reddys belongs to analysts' top-rated companies list?

    View Stock Screeners

    Dr. Reddys Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Dr. Reddys Share Recommendations

    Recent Recos

    HOLD

    Current

    Mean Recos by 38 Analysts

    Strong
    Sell
    SellHoldBuyStrong
    Buy
    • Target₹5240
    • OrganizationMotilal Oswal Financial Services
    • NEUTRAL

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy9988
    Buy109912
    Hold9998
    Sell8788
    Strong Sell3332
    # Analysts38373738

    Dr. Reddys Share Price Forecast

    • PRICE

    • REVENUE

    • EARNINGS

    • Get multiple analysts’ prediction on Dr. Reddys

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Dr. Reddys

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Dr. Reddys

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Peer Comparison

    • Dr. Reddys Stock Performance

    • Ratio Performance

      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Dr. Reddys19.704.0019.3525.9513.9612.2224.9418.12271.472.380.050.19
      Divis Labs67.667.8314.2817.7612.6213.1230.5023.4768.698.460.000.00
      Cipla30.824.0411.9617.789.509.8419.0312.4634.723.380.020.16
      Mankind Pharma57.369.4317.2421.6913.1913.9619.4614.8232.002.320.020.09
      Torrent Pharma51.8210.5320.0922.798.296.1722.6612.9436.790.980.852.24
      Add More
      Annual Ratios (%)

      Choose from Peers

      • Cadila Healthcare
      • Aurobindo Pharma
      • Lupin
      • Alkem Labs
      • Biocon

      Choose from Stocks

      Peers InsightsDr. Reddys

        Do you find these insights useful?

        • hate it

        • meh

        • love it

        Dr. Reddys Shareholding Pattern

        • QOQ Change

        • Total Shareholdings

        • Loading...
          Showing Dr. Reddys Shareholding as on 30 Jun 2023
          Category30 Jun 202331 Mar 202331 Dec 202230 Sep 2022
          Promoters26.6926.7026.7026.71
          Pledge0.000.000.000.00
          FII26.9927.2527.2926.26
          DII21.9823.0323.3524.60
          Mutual Funds9.319.8710.9412.84
          Others24.3423.0222.6622.43
        • Showing Shareholding as on 30 Jun 2023
          CategoryNo. of SharesPercentage% Change QoQ
          Promoters4,44,61,12826.69 %-0.01
          Pledge00.00 %0.00
          FII4,49,63,29626.99 %-0.26
          DII3,66,01,79621.98 %-1.05
          MF1,55,03,9209.31 %-0.56
          Others4,05,29,28124.34 %1.32

        MF Ownership

        MF Ownership as on 31 August 2023

        Dr. Reddys F&O Quote

        • Futures

        • Options

          • Expiry

          Price

          5,621.80153.30 (2.80%)

          Open Interest

          25,38,00080,375 (3.17%)

          OpenHighLowPrev CloseContracts TradedTurnover (₹ Lakhs)
          5,470.155,665.305,470.155,468.505,75440,353.19

          Open Interest as of 29 Sep 2023

        Corporate Actions

        • Dr. Reddys Board Meeting/AGM

        • Dr. Reddys Dividends

        • Others
        • Meeting DateAnnounced onPurposeDetails
          Oct 27, 2023Sep 22, 2023Board MeetingQuarterly Results
          Jul 27, 2023May 10, 2023AGMBook closure from 12 Jul, 2023 to 14 Jul, 2023
          Jul 26, 2023Jun 21, 2023Board MeetingQuarterly Results
          May 10, 2023Mar 23, 2023Board MeetingAudited Results & Final Dividend
          Jan 25, 2023Dec 27, 2022Board MeetingQuarterly Results
        • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
          Final800%40.0Jul 11, 2023May 10, 2023
          Final600%30.0Jul 11, 2022May 19, 2022
          Final500%25.0Jul 09, 2021May 14, 2021
          Final500%25.0Jul 13, 2020May 20, 2020
          Final400%20.0Jul 15, 2019May 17, 2019
        • All TypesEx-DateRecord DateAnnounced onDetails
          BonusAug 28, 2006Aug 29, 2006May 31, 2006Bonus Ratio: 1 share(s) for every 1 shares held
          SplitsOct 10, 2001Oct 25, 2001Jul 31, 2001Split: Old FV10.0| New FV:5.0
          BonusApr 08, 1994May 03, 1994Mar 24, 1994Bonus Ratio: 2 share(s) for every 1 shares held
          BonusDec 04, 1992Dec 22, 1992Sep 30, 1992Bonus Ratio: 1 share(s) for every 1 shares held
          Bonus-Dec 03, 1991Dec 03, 1991Bonus Ratio: 1 share(s) for every 2 shares held

        About Dr. Reddys

        Dr. Reddy's Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 93,054.56 Crore) operating in Pharmaceuticals sector. Dr. Reddy's Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals, Licence Fees, Other Operating Revenue, Spent Chemicals, Service Income and Scrap for the year ending 31-Mar-2022. Show More

        • Executives

        • Auditors

        • GV

          G V Prasad

          Co-Chairman & Manag. Director
          KS

          K Satish Reddy

          Chairman
          DS

          Deepak Sapra

          Chief Executive Officer
          EI

          Erez Israeli

          Chief Executive Officer
          MV

          M V Ramana

          CEO - Branded Markets
          AM

          Arun Madhavan Kumar

          Independent Director
          Show More
        • S R Batliboi & Associates LLP

        Key Indices Listed on

        Nifty 50, Nifty 100, Nifty 200, + 34 more

        Address

        8-2-337,Road No. 3,Hyderabad, Telangana - 500034

        Brands

        Dr. Reddy's Laboratories

        FAQs about Dr. Reddys share

        • 1. What is Dr. Reddys share price and what are the returns for Dr. Reddys share?
          As on 29 Sep, 2023, 03:55 PM IST Dr. Reddys share price was up by 2.90% basis the previous closing price of Rs 5,429.1. Dr. Reddys share price was Rs 5,587.00. Return Performance of Dr. Reddys Shares:
          • 1 Week: Dr. Reddys share price moved up by 1.27%
          • 1 Month: Dr. Reddys share price moved down by 2.39%
          • 3 Month: Dr. Reddys share price moved up by 9.38%
          • 6 Month: Dr. Reddys share price moved up by 22.31%
        • 2. Who are the peers for Dr. Reddys in Pharmaceuticals sector?
          Top 10 Peers for Dr. Reddys are Cipla Ltd., Divi's Laboratories Ltd., Mankind Pharma Ltd., Torrent Pharmaceuticals Ltd., Zydus Lifesciences Ltd., Lupin Ltd., Aurobindo Pharma Ltd., Alkem Laboratories Ltd., Biocon Ltd. and Syngene International Ltd.
        • 3. Who owns Dr. Reddys?
            • Promoter holding have gone down from 26.71 (30 Sep 2022) to 26.69 (30 Jun 2023)
            • Domestic Institutional Investors holding have gone down from 24.6 (30 Sep 2022) to 21.98 (30 Jun 2023)
            • Foreign Institutional Investors holding has gone up from 26.26 (30 Sep 2022) to 26.99 (30 Jun 2023)
            • Other investor holding has gone up from 22.43 (30 Sep 2022) to 24.34 (30 Jun 2023)
        • 4. What has been highest price of Dr. Reddys share in last 52 weeks?
          Dr. Reddys share price saw a 52 week high of Rs 5,989.70 and 52 week low of Rs 4,175.10.
        • 5. What are the key metrics to analyse Dr. Reddys Share Price?
          Key Metrics for Dr. Reddys are:
          • PE Ratio of Dr. Reddys is 19.70
          • Earning per share of Dr. Reddys is 283.58
          • Price/Sales ratio of Dr. Reddys is 3.12
          • Price to Book ratio of Dr. Reddys is 4.16
        • 6. What is the market cap of Dr. Reddys?
          Market Capitalization of Dr. Reddys stock is Rs 93,054.56 Cr.

        DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

        DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

        By using this site, you agree to the Terms of Service and Privacy Policy.

        The Economic Times